Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Sarepta Therapeutics
(NQ:
SRPT
)
132.74
+0.24 (+0.18%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,010,128
Open
132.04
Bid (Size)
131.25 (1)
Ask (Size)
132.70 (1)
Prev. Close
132.50
Today's Range
129.56 - 133.06
52wk Range
55.25 - 146.68
Shares Outstanding
93,148,652
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
3 Biotech Stocks With the Potential to Make You an Overnight Millionaire
May 04, 2024
Don’t miss out on these stocks that could rock your portfolio with massive growth following FDA approvals and breakthrough treatments.
Via
InvestorPlace
Exposures
Product Safety
Gene Therapy Pioneer Jerry R. Mendell, M.D., Named to Inaugural TIME100 Health List of the 100 Most Influential People in Global Health
May 03, 2024
From
Sarepta Therapeutics, Inc.
Via
Business Wire
Performance
YTD
+37.97%
+37.97%
1 Month
+13.17%
+13.17%
3 Month
+6.29%
+6.29%
6 Month
+59.97%
+59.97%
1 Year
+0.86%
+0.86%
More News
Read More
What Analysts Are Saying About Sarepta Therapeutics Stock
May 02, 2024
Via
Benzinga
Apple, Kellanova And 3 Stocks To Watch Heading Into Thursday
May 02, 2024
Via
Benzinga
SRPT Stock Earnings: Sarepta Therapeutics Beats EPS, Beats Revenue for Q1 2024
May 01, 2024
Via
InvestorPlace
Sarepta Therapeutics: Q4 Earnings Insights
February 28, 2024
Via
Benzinga
Sarepta Therapeutics (SRPT) Q1 2024 Earnings Call Transcript
May 01, 2024
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Sarepta Therapeutics Announces First Quarter 2024 Financial Results and Recent Corporate Developments
May 01, 2024
From
Sarepta Therapeutics, Inc.
Via
Business Wire
1 Top Growth Stock to Buy and Hold for 10 Years
May 01, 2024
Via
The Motley Fool
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 30, 2024
From
Sarepta Therapeutics, Inc.
Via
Business Wire
Sarepta Therapeutics Stock Shows Improved Technical Strength
April 29, 2024
Via
Investor's Business Daily
Sarepta Therapeutics to Announce First Quarter 2024 Financial Results
April 24, 2024
From
Sarepta Therapeutics, Inc.
Via
Business Wire
Why Sarepta's First-Quarter Report Is Already Dead In The Water: Analyst
April 08, 2024
Via
Investor's Business Daily
2 Biotech Stocks to Buy Hand Over Fist in April
April 06, 2024
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
April 04, 2024
Via
Benzinga
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 29, 2024
From
Sarepta Therapeutics, Inc.
Via
Business Wire
How Sleeper Biotech Solid Biosciences, With A 687% Gain, Is Making A Comeback
March 28, 2024
Via
Investor's Business Daily
Does This 1 New Threat Make Sarepta Therapeutics Stock Worth Selling?
March 13, 2024
Via
The Motley Fool
This Gene Therapy Player Duchenne Data Is Impressive, Analyst Upgrades REGENXBIO
March 08, 2024
Via
Benzinga
Got $1,000? Buy These Hot Growth Stocks Before They Take Off.
March 08, 2024
Via
The Motley Fool
Sarepta Therapeutics Stock Has 73% Upside, According to 1 Wall Street Analyst
March 04, 2024
Via
The Motley Fool
Sarepta Therapeutics to Present at Upcoming Investor Conferences
March 04, 2024
From
Sarepta Therapeutics, Inc.
Via
Business Wire
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 29, 2024
From
Sarepta Therapeutics, Inc.
Via
Business Wire
Sarepta Therapeutics Announces Call for Applications for the 7th Annual Route 79, The Duchenne Scholarship Program
February 29, 2024
From
Sarepta Therapeutics, Inc.
Via
Business Wire
Sarepta Therapeutics (SRPT) Q4 2023 Earnings Call Transcript
February 29, 2024
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.